# Civamide Nasal Solution for the Treatment of Dry Eye

> **NCT02116244** · PHASE2 · COMPLETED · sponsor: **Winston Laboratories** · enrollment: 31 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** Civamide Nasal Spray

## Key facts

- **NCT ID:** NCT02116244
- **Lead sponsor:** Winston Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2017-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02116244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02116244, "Civamide Nasal Solution for the Treatment of Dry Eye". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02116244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*